Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
GlaxoSmithKline PLC ADR
GSKCurrent price
1 301 GBX
-13.05 GBX (-0.99%)
Last closed
35.11 USD
Company
www.gsk.com
ISIN
US37733W2044
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
London Exchange
Capitalization
74 040 672 256 USD
Yield for 12 month
-3.16 %
1Y
3Y
5Y
10Y
15Y
GSK
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development, as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. Address: 980 Great West Road, Brentford, United Kingdom, TW8 9GS
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
44.69 USDP/E ratio
23.2628Dividend Yield
4.49 %Current Year
+39 022 532 399 USD
Last Year
+37 730 702 323 USD
Current Quarter
+10 308 906 937 USD
Last Quarter
+10 308 906 937 USD
Current Year
+27 344 594 386 USD
Last Year
+25 437 729 673 USD
Current Quarter
+7 224 726 966 USD
Last Quarter
+7 224 726 966 USD
Key Figures GSK
1 year
3 years
5 years
10 years
EBITDA
9 256 999 936 USD
Operating Margin TTM
PE Ratio
23.2628
Return On Assets TTM
7.24 %
PEG Ratio
0.7629
Return On Equity TTM
21.85 %
Wall Street Target Price
44.69 USD
Revenue TTM
31 310 999 552 USD
Book Value
3.43 USD
Revenue Per Share TTM
Dividend Share
0.61 USD
Quarterly Revenue Growth YOY
-1.7 %
Dividend Yield
4.49 %
Gross Profit TTM
19 917 000 000 USD
Earnings per share
1.56 USD
Diluted Eps TTM
1.56 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
-28.2 %
Profit Margin
8.02 %
Dividend Analytics GSK
Dividend growth over 5 years
-16 %Continuous growth
–Payout Ratio 5 years average
68 %Dividend History GSK
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
1.56
Ex Dividend Date
15.11.2024
Forward Annual Dividend Yield
4.31 %
Last Split Factor
1226:1000
Payout Ratio
37.07 %
Last Split Date
22.07.2022
Dividend Date
10.10.2024
Stock Valuation GSK
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
23.2628
Forward PE
7.7821
Enterprise Value Revenue
2.21
Price Sales TTM
2.3647
Enterprise Value EBITDA
10.3189
Price Book MRQ
4.1031
Financials GSK
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators GSK
For 52 weeks
33.11 USD
45.36 USD
50 Day MA
39.96 USD
Shares Short Prior Month
11 693 251
200 Day MA
41.1 USD
Short Ratio
3.29
Shares Short
16 545 524
Short Percent
0.72 %
BeatStart